Hysterectomy

2
Pipeline Programs
3
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
1
MorphinePhase 35 trials
Active Trials
NCT00803283Terminated2Est. Dec 2008
NCT00766506Terminated108Est. Sep 2008
NCT00478023Completed854Est. Apr 2008
+2 more trials
Alkermes
AlkermesDUBLIN 4, Ireland
1 program
1
N1539Phase 21 trial
Active Trials
NCT01084161CompletedEst. Jan 2011
Verona Pharma
Verona PharmaUK - London
1 program
Robotic-assisted hysterectomyN/A1 trial
Active Trials
NCT06138197Completed150Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Johnson & JohnsonMorphine
Johnson & JohnsonMorphine
Johnson & JohnsonMorphine
Johnson & JohnsonMorphine
Johnson & JohnsonMorphine
AlkermesN1539
Verona PharmaRobotic-assisted hysterectomy

Clinical Trials (7)

Total enrollment: 1,810 patients across 7 trials

An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic Surgery

Start: May 2008Est. completion: Sep 2008108 patients
Phase 4Terminated

A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously

Start: Jun 2004Est. completion: Apr 2005657 patients
Phase 4Completed

An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Thai Participants With Chronic Non-Malignant Pain

Start: Apr 2004Est. completion: Mar 200839 patients
Phase 4Completed

A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain

Start: Nov 2008Est. completion: Dec 20082 patients
Phase 3Terminated

A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy

Start: May 2007Est. completion: Apr 2008854 patients
Phase 3Completed

Study to Evaluate the Efficacy, Safety and Tolerability of N1539

Start: Mar 2010Est. completion: Jan 2011
Phase 2Completed
NCT06138197Verona PharmaRobotic-assisted hysterectomy

Comparison of Three Robotic Platforms for Hysterectomy

Start: Jan 2024Est. completion: Dec 2024150 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space